INTEST director granted 12,000 INTT shares

INTEST CORP director Jeffrey A. Beck received an award of 12,000 shares of common stock.

Rhea-AI Filing Summary

INTEST CORP director Jeffrey A. Beck received an award of 12,000 shares of common stock. The grant was recorded at no cash cost per share and represents a compensation-related acquisition rather than an open-market purchase. After this grant, Beck directly holds 79,500 shares of INTT common stock.

Insights

Equity Compensation Analyst

Director received 12,000-share stock grant, increasing direct holdings.

Director Jeffrey A. Beck acquired 12,000 shares of INTEST CORP common stock through a grant or award, at a reported price of $0.0000 per share. This indicates a compensation-related issuance rather than a market transaction.

Following the grant, Beck directly holds 79,500 common shares. With no derivative positions reported in this filing and no sales, the transaction increases his equity exposure. As a standard director equity award, it is generally routine and does not by itself signal a change in the company’s outlook.

Insider Trade Summary

Grant/Award: 12,000 shares

Grant/Award 1 txn

Insider Beck Jeffrey A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 79,500 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INTEST CORP (INTT) report for Jeffrey A. Beck?

INTEST CORP reported that director Jeffrey A. Beck acquired 12,000 shares of common stock through a grant or award. The transaction used code A, indicating a compensation-related acquisition rather than an open-market trade, and was priced at $0.0000 per share.

Was the INTEST CORP (INTT) insider transaction a stock purchase or a grant?

The transaction was a stock grant, not an open-market purchase. Code A and the reported price of $0.0000 per share show that Jeffrey A. Beck received 12,000 shares as a grant or award, typically part of director compensation.

How many INTEST CORP (INTT) shares does Jeffrey A. Beck hold after this Form 4?

After the reported grant, Jeffrey A. Beck directly holds 79,500 shares of INTEST CORP common stock. This total reflects his position following the 12,000-share award, and no derivative holdings are listed in the filing’s derivative summary section.

Does the INTEST CORP (INTT) Form 4 show any insider selling activity?

The Form 4 shows no insider selling activity. It reports a single transaction coded A, representing a 12,000-share grant to director Jeffrey A. Beck, with no sales, dispositions, or derivative exercises disclosed in the transaction summary.

What does transaction code A mean in the INTEST CORP (INTT) Form 4?

Transaction code A on the INTEST CORP Form 4 denotes a grant, award, or other acquisition. In this case, it indicates that Jeffrey A. Beck received 12,000 shares of common stock as equity compensation, rather than buying shares in the open market.

Is the INTEST CORP (INTT) insider transaction a direct or indirect holding?

The filing classifies the holding as direct. The transaction is marked with ownership code D, meaning the 12,000-share grant to Jeffrey A. Beck is held directly in his name, without an intermediate entity disclosed for this position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 05:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beck Jeffrey A

(Last) (First) (Middle)

C/O INTEST CORP

804 EAST GATE DR, SUITE 200

(Street)

MT. LAUREL NEW JERSEY 08054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		A		12,000	A	$0	79,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Duncan Gilmour, Attorney-in-Fact for Jeffrey A. Beck	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)